Recap - It was a shortened trading week in the U.S. with markets closed the entirety of Friday and half of Thursday, though activity and volatility in the healthcare … Continue Reading
Read NowRecap - The announcement came two weeks ahead of schedule, and Afrezza is now approved to improve glycemic control in adults with diabetes mellitus. Afrezza’s label includes a Black Box Warning … Continue Reading
Read NowRecap - The “Hold Your Nose, Buy the Panic” crowd is being vindicated as biotech recovers from a 2-month correction, and makes its way towards old highs. … Continue Reading
Read NowRecap - Orexigen Therapeutics (OREX) got an unexpected surprise on Wednesday when the FDA extended its review of the New Drug Application for NB32, the company’s investigational drug … Continue Reading
Read NowRecap - First, we’re hosting a networking event for healthcare investors, traders, and analysts on June 17th – details and RSVP here. It’s all about dialog, an investor’s best friend when you’ve … Continue Reading
Read NowRecap - These trades aren’t over yet, and you can catch up on the fundamental theses at PropThink.com. Below, our weekly recap. Shares of Biodelivery Sciences (BDSI) came close to … Continue Reading
Read NowInsights - Before we get into the event of the week – the ASCO abstract drop on Wednesday evening – lets take a look at what’s been … Continue Reading
Read Now
